IRDs Incur Disproportionate Societal Burden
While health care and societal costs are routinely modelled for most diseases, there’s a lack of comprehensive data and cost-of-illness studies for IRDs.
Read MoreApr 8, 2024
While health care and societal costs are routinely modelled for most diseases, there’s a lack of comprehensive data and cost-of-illness studies for IRDs.
Read MoreApr 7, 2024
Researchers compared the sensitivity of an elastic-scattering spectroscopy device versus dermatologist examinations for detecting skin lesions.
Read MoreApr 5, 2024
Researchers examined why patients who experience seizures may also face a higher degree of vascular disease.
Read MoreApr 4, 2024
There is significant underdiagnosis and suboptimal clinical management of coconut allergy in the US.
Read MoreApr 4, 2024
There is significant underdiagnosis and suboptimal clinical management of coconut allergy in the US.
Read MoreApr 3, 2024
Patients had lower blood pressure readings at home, suggesting telemedicine may be a promising resource for improving hypertension management.
Read MoreApr 2, 2024
Frailty represents a comprehensive health measure in epilepsy, according to findings published in Epilepsia.
Read MoreApr 2, 2024
For patients with epilepsy, having public health insurance and a shorter travel time to an epilepsy center influences receipt of timely surgical treatment.
Read MoreApr 2, 2024
Both physicians in training and well-established physicians should stay abreast of healthcare industry trends, as they can significantly impact compensation.
Read MoreApr 2, 2024
A recent analysis compared low-dose computed tomography with chest radiography in a sample of patients eligible for the National Lung Screening Trial.
Read MoreApr 1, 2024
Phase 2 trial results show reductions in the abscesses and inflammatory nodule count were induced by topical treatment with ruxolitinib versus vehicle.
Read MoreApr 1, 2024
Researchers observed consistent response rates through 4 years of bimekizumab therapy in patients with psoriasis from several trials.
Read MoreApr 1, 2024
The anti-OX40 antibody amlitelimab showed maintenance of response even after treatment discontinuation in the STREAM-AD study.
Read MoreApr 1, 2024
Results from the KNOCKOUT trial show high induction doses of the IL-23 blocker risankizumab led to a marked reduction in resident memory T cells.
Read MoreApr 1, 2024
More than 80% of patients with alopecia areata who responded to baricitinib at week 52 maintained their response until week 152 in the BRAVE-AA trials.
Read MoreMar 31, 2024
Differences in psoriasis outcomes are more likely due to socioeconomic factors than patient race, according to recent findings.
Read MoreMar 29, 2024
Dr. Puneet Jolly shares how same-day biopsy and treatment can reduce costs and treatment fatigue for patients with field cancerization.
Read MoreMar 28, 2024
Arnold Schwarzenegger’s disclosure of his recent pacemaker surgery shines a global spotlight on the procedure, potentially spurring increased demand.
Read MoreMar 28, 2024
“Lung ultrasound score is better than diaphragm excursion at maximal deep inspiration for diagnosing severe lung hyperinflation,” researchers wrote.
Read MoreMar 28, 2024
New injectable weight loss medications are highly sought-after, causing shortages. Prescribing should not solely depend on patient requests.
Read More